Huiyang Yuan
Jinan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Investigating the efficacy of immune checkpoint inhibitors in clear cell renal cell carcinoma based on methylation cross talk scoring.
Journal: Medicine
Published: March 18, 2025
Comprehensive analyses of telomerase component DKC1 and its association with clinical, molecular and immune landscapes in uterine corpus endometrial carcinoma.
Journal: Frontiers in cell and developmental biology
Published: March 12, 2025
SMYD3 Promotes Immune Evasion in Clear Cell Renal Cell Carcinoma via SREBP1-Mediated Transactivation of CD47.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 20, 2024
The immunotherapy-based combination associated score as a robust predictor for outcome and response to combination of immunotherapy and VEGF inhibitors in renal cell carcinoma.
Journal: Computers in biology and medicine
Published: April 06, 2024
High DNA methylation age deceleration defines an aggressive phenotype with immunoexclusion environments in endometrial carcinoma.
Journal: Frontiers in immunology
Published: April 18, 2023
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Journal: Biology of sex differences
Published: January 23, 2023
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.
Journal: Frontiers in oncology
Published: December 29, 2022
The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma.
Journal: Frontiers in immunology
Published: December 17, 2022
Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance.
Journal: Clinical and translational medicine
Published: July 31, 2022
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
Journal: Frontiers in immunology
Published: June 16, 2022
Synergistic effects of telomerase reverse transcriptase and regulator of telomere elongation helicase 1 on aggressiveness and outcomes in adrenocortical carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: February 08, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026